Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
Fruquintinib in the Treatment of Soft Tissue Sarcoma
- First Posted Date
- 2021-12-02
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 31
- Registration Number
- NCT05142631
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Axillary Sentinel or Targeted Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy in Node-positive Breast Cancer
Phase 2
- Conditions
- Breast Cancer Female
- Interventions
- Procedure: sentinel lymph node biopsy or targeted axillary dissection alone
- First Posted Date
- 2021-12-02
- Last Posted Date
- 2021-12-02
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 100
- Registration Number
- NCT05141630
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen
- First Posted Date
- 2021-11-30
- Last Posted Date
- 2021-11-30
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 10
- Registration Number
- NCT05138159
- Locations
- 🇨🇳
Fudan University, Shanghai, China
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
Phase 1
- Conditions
- GlioblastomaColon CancerMedulloblastomaHepatocellular Carcinoma
- Interventions
- Biological: NKG2D-based CAR T-cells
- First Posted Date
- 2021-11-23
- Last Posted Date
- 2021-11-23
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 3
- Registration Number
- NCT05131763
- Locations
- 🇨🇳
Xunyang Changchun Shihua Hospital, Jiujiang, Jiangxi, China
Anlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma
Phase 2
Not yet recruiting
- Conditions
- Renal Cell Carcinoma
- Interventions
- First Posted Date
- 2021-11-18
- Last Posted Date
- 2021-11-18
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 30
- Registration Number
- NCT05124431
- Locations
- 🇨🇳
270 Dongan Road, Fudan University Shanghai Cancer Center, Shanghai, China
RWE About QOL and Compliance of Patients With OFS in China
- Conditions
- Hormone Receptor-positive Breast CancerBreast CancerQuality of Life
- Interventions
- Drug: 1M GnRHaDrug: 3M GnRHa
- First Posted Date
- 2021-11-16
- Last Posted Date
- 2021-11-16
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 500
- Registration Number
- NCT05122377
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
Camrelizumab Plus Pyrotinib Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Phase 2
- Conditions
- Gastric NeoplasmsGastroesophageal Junction Adenocarcinoma
- Interventions
- First Posted Date
- 2021-11-08
- Last Posted Date
- 2021-11-08
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 65
- Registration Number
- NCT05111444
- Locations
- 🇨🇳
270 Dongan Road, Fudan University Shanghai Cancer Center, Shanghai, China
Cryoablation Combined With Sintilimab Plus Lenvatinib In Previously Treated Unresectable Liver Metastasis From Solid Tumors
Phase 2
Recruiting
- Conditions
- Liver Metastasis
- Interventions
- First Posted Date
- 2021-10-28
- Last Posted Date
- 2022-11-10
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 25
- Registration Number
- NCT05098847
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer
- First Posted Date
- 2021-10-27
- Last Posted Date
- 2021-10-27
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 102
- Registration Number
- NCT05095636
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Anatomical Location and Metastasis Pattern of Intrapulmonary Lymph Nodes in NSCLC (ECTOP-1010)
Recruiting
- Conditions
- Non-small Cell Lung CancerCarcinoma
- Interventions
- Procedure: pulmonary lobectomy
- First Posted Date
- 2021-10-26
- Last Posted Date
- 2023-07-20
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 500
- Registration Number
- NCT05094882
- Locations
- 🇨🇳
Fudan University Cancer Center, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath